TechnoDerma Medicines
About:
TechnoDerma Medicines is engaged in the research and development of skin drugs for external use.
Website: http://www.tkskin.com
Top Investors: CDH Investments, Kaitai Capital, Viva BioInnovator, Oceanpine Capital, Linden Asset
Description:
TechnoDerma Medicines is a private clinical-stage biopharmaceutical company. They develop programs that include innovative therapies for the treatment of androgenetic alopecia, atopic dermatitis/eczema, psoriasis, and lupus erythematosus, among other diseases.
Total Funding Amount:
10M CNY
Headquarters Location:
Xuzhou, Jiangsu, China
Founded Date:
2014-01-01
Contact Email:
info(AT)tkskin.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-01-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai